Anixa Biosciences Inc. (ANIX)
NASDAQ: ANIX
· Real-Time Price · USD
4.40
-0.07 (-1.57%)
At close: Oct 16, 2025, 3:59 PM
4.41
0.23%
After-hours: Oct 16, 2025, 07:19 PM EDT
-1.57% (1D)
| Bid | 4.25 |
| Market Cap | 144.82M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -8.86M |
| EPS (ttm) | -0.34 |
| PE Ratio (ttm) | -12.94 |
| Forward PE | -12.74 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 4.72 |
| Volume | 230,886 |
| Avg. Volume (20D) | 154,671 |
| Open | 4.46 |
| Previous Close | 4.47 |
| Day's Range | 4.33 - 4.67 |
| 52-Week Range | 2.07 - 4.98 |
| Beta | 0.70 |
| Ex-Dividend Date | n/a |
About ANIX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ANIX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ANIX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
+23.19%
Anixa Biosciences shares are trading higher after ...
Unlock content with
Pro Subscription
4 months ago
+12.45%
Anixa Biosciences shares are trading higher after the company announced it completed enrollment for its Phase 1 breast cancer vaccine clinical trial.
